TLV · PPBT.TA
Purple Biotech Ltd.
₪0.01₪0.00 (0.0%)
Purple Biotech Ltd.’s quoted price sits in the upper half of its reported 52-week range, 41.18% below the high.
Loading market information…
TLV · EMTC-M.TA · ILA
Stock price, earnings
Quote as of Feb 17, 2026, 03:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Elbit Medical Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 26.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Elbit Medical Technologies Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Elbit Medical Technologies Ltd functions as an investment holding company, with its core activities centered on the innovation, production, and global commercialization of therapeutic medical devices. The company maintains a presence across the United States, Europe, and other international territories. A key initiative involves the advancement of a magnetic resonance imaging (MRI) guided focused ultrasound treatment system, designed to tackle a range of medical challenges, including various cancers (oncology), gynecological conditions, neurological disorders, and tumors. Additionally, Elbit Medical Technologies is engaged in the extensive study and creation of medical products leveraging stem cells, predominantly sourced from umbilical cord blood. These stem cell applications are critical for bone marrow transplants in individuals affected by leukemia, lymphatic system cancers, non-malignant hematological diseases, and inherited metabolic genetic conditions. Headquartered in Petah Tikva, Israel, Elbit Medical Technologies Ltd is a wholly-owned subsidiary of Exigent Management Ltd.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₪0.01₪0.00 (0.0%)
Purple Biotech Ltd.’s quoted price sits in the upper half of its reported 52-week range, 41.18% below the high.
₪0.31+₪0.02 (+6.27%)
Allmed Solutions Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.69% below the high.
₪3.13+₪0.15 (+5.18%)
BioLight Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.9% below the high.
₪1.21-₪0.00 (-0.08%)
Merchavia Holdings and Investments Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.19% below the high.
₪1.59₪0.00 (0.0%)
Identi Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.96% below the high.
₪66.65+₪6.74 (+11.25%)
Bio-View Ltd’s quoted price sits in the lower half of its reported 52-week range, 80.04% below the high.
₪2.21₪0.00 (0.0%)
PlantArc Bio Ltd.’s quoted price sits in the lower half of its reported 52-week range, 77.91% below the high.
₪0.83-₪0.02 (-2.57%)
Imed Infinity Medical-Limited Partnership’s quoted price sits in the upper half of its reported 52-week range, 47.88% below the high.